Compare eBay Inc (EBAY) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Repligen Corporation Common Stock — how do they compare? eBay Inc trades at $116.73 (market cap $51.80B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: eBay Inc is far larger — about 4.6× Repligen Corporation Common Stock's market cap, and eBay Inc pays a 1.07% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Repligen Corporation Common Stock for 0 Days on average.
| EBAY | RGEN | |
|---|---|---|
Market Cap | $51.80B | $11.14B |
Volume | 3,344,419 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $194.57 |
52-Week Low | $79.41 | $102.87 |
Typical Hold Time | 134 Days | 0 Days |
Enterprise Value | $55.63B | $11.02B |
Dividend Yield | 1.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $116.88, up 1.95% today, near the consensus price target of $117.89. The stock shows a bullish technical trend with strong moving average signals, though RSI levels indicate potential overbought conditions. Fundamentally, the company maintains robust profitability with a net income margin of 18.57% and has beaten earnings estimates for three consecutive quarters. Recent news highlights strategic focus on collectibles and live commerce growth.
EBAY presents a balanced outlook with solid earnings momentum and high profitability offset by valuation concerns and competitive pressures. Upside potential exists if the company executes its growth initiatives in collectibles and AI, but risks include slowing advertising growth and insider selling activity. Analyst sentiment is mixed, with nearly half recommending Buy but some expressing caution on valuation.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
